ONE KENDALL SQUARE. BUILDING 600-700, CAMBRIDGE, MA
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Announces Oversubscribed $85 Million Private Placement
Korro Bio, Inc. Amends Employment Agreement for Jeffrey Cerio
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Submission Upload
Correspondence
Post-Effective Amendment to Registration Statement